Sales and Marketing

Showing 15 posts of 11527 posts found.

Genentech’s retiring R&D head to be replaced by MIT executive

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Roche, appointment

Michael Varney, industry veteran and Head of Research & Development at Genentech, has announced he is to leave the role …

Top Ten most popular articles on Pharmafile.com this week

May 15, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

The news this week continues to be dominated by COVID-19 vaccines and treatments, with the NIAID announcing the launch of …

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020 Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …

Takeda’s subcutaneous Entyvio approved in Europe for maintenance of moderate to severe Crohn’s and ulcerative colitis

May 11, 2020 Sales and Marketing Crohn’s disease, Entyvio, Takeda, crohn's disease, ulcerative colitis

The European Commission has awarded marketing approval to Takeda’s subcutaneous formulation of its gut-selective biologic therapy Entyvio (vedolizumab) as a …

Latest large hydroxychloroquine study suggests it does not help treat COVID-19

May 11, 2020 Sales and Marketing COVID-91, coronavirus, hydroxychloroquine

The results of another study into the use of hydroxychloroquine in COVID-19 patients has cast further doubts on its effectiveness …

Lynparza combo authorised in US for first-line maintenance of HRD-positive advanced ovarian cancer

May 11, 2020 Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer

Lynparza (olaparib), developed by AstraZeneca and MSD, has secured FDA approval when paired with bevacizumab as a first-line maintenance treatment …

Eli Lilly’s Retevmo approved by FDA to treat lung and thyroid cancers

May 11, 2020 Sales and Marketing COVID-19, coronavirus

The FDA has announced that Retevmo (selpercatinib) has been approved to treat both non-small-cell lung cancer (NSCLC) and medullary thyroid …

NIAID announces the launch of second remdesivir trial for COVID-19 patients

May 11, 2020 Sales and Marketing COVID-19, coronavirus, niaid, remdesivier

The US National Institute of Allergy and Infectious Diseases (NAID) has announced that it is enrolling COVID-19 patients in hospital …

NICE gives thumbs-up to Roche’s Kadcyla in HER2+ breast cancer sub-population

May 7, 2020 Sales and Marketing Cancer, Kadcyla, NHS, NICE, Roche, UK, breast cancer

NICE has revealed that it has recommended the NHS use of Roche’s Kadcyla (trastuzumab emtansine) for HER2+ breast cancer in …

FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14

May 7, 2020 Sales and Marketing Incyte, Novartis, Tabrecta, pharma

The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …

AZ’s Farxiga becomes first FDA-approved SGLT2 inhibitor for heart failure with reduced ejection fraction

May 6, 2020 Research and Development, Sales and Marketing AstraZeneca, FDA, farxiga, heart failure

The FDA has moved to approve an oral tablet formulation of AstraZeneca’s Farxiga (dapagliflozin) to reduce the risk of cardiovascular …

Portola Pharmaceuticals to merge with Alexion in $1.41bn cash deal

May 6, 2020 Research and Development, Sales and Marketing Alexion, Portola Pharmaceuticals, pharma

Alexion has announced it is to acquire Boston-based blood disorder specialist Portola Pharmaceuticals in a transaction to the value of …

Working Life Interview: Kim Stratton, CEO, Orphazyme

May 4, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, Orphazyme, Working Life

“Every professional faces challenges. As a woman in industry, particularly in leadership, it adds another dimension to those challenges in …

Lonza and Moderna enter agreement to mass produce coronavirus vaccine

May 4, 2020 Sales and Marketing COVID-19, coronavirus

Lonza Group AG and Moderna Inc have entered a deal to develop 1 billion doses of coronavirus vaccines a year. …
The Gateway to Local Adoption Series

Latest content